Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs used to treat immune conditions may cause different types of hair loss.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Hair transplantation is safe and effective for permanent hair loss due to scarring, with high patient satisfaction.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Testing hair roots with a special dye is a simple, non-invasive way to check disease progress in pemphigus vulgaris patients.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Mesotherapy and platelet-rich plasma treatments may help with hair loss, but their safety and effectiveness are still uncertain.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Effective symptom management in IBD improves quality of life and prevents complications.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

High TSPEAR levels in colorectal cancer predict worse outcomes.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.